TrialAntimicrobial agents and chemotherapy2020

A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study.

Etienne F Dumont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.